Pills, power, and policy : the struggle for drug reform in Cold War America and its consequences
Author(s)
Bibliographic Information
Pills, power, and policy : the struggle for drug reform in Cold War America and its consequences
（California/Milbank series on health and the public, 23）
University of California Press , Millbank Memorial Fund, c2012
- : pbk
Available at 2 libraries
Note
Bibliography: p. 267-281
Includes index
Description and Table of Contents
Description
Since the 1950s, the American pharmaceutical industry has been heavily criticized for its profit levels, the high cost of prescription drugs, drug safety problems, and more, yet it has, together with the medical profession, staunchly and successfully opposed regulation. "Pills, Power, and Policy" offers a lucid history of how the American drug industry and key sectors of the medical profession came to be allies against pharmaceutical reform. It details the political strategies they have used to influence public opinion, shape legislative reform, and define the regulatory environment of prescription drugs. Untangling the complex relationships between drug companies, physicians, and academic researchers, the book provides essential historical context for understanding how corporate interests came to dominate American health care policy after World War II.
Table of Contents
Foreword Acknowledgments Introduction: Pharmaceutical Politics, Then and Now Part I: Forging Pharmaceutical Relations 1. Knowledgeable Relations: The Building of a Pharmaceutical Research Network 2. Workforce Relations: The Invention of the Pharmaceutical Postdoctoral Fellowship 3. Professional Relations: Crafting the Public Image of the Health Care Team Part II: Allied against Reform 4. Cold War Alliances: Kefauver's Bid for Pharmaceutical Reform 5. Expert Alliances: The Creation of the Drug Research Board 6. Generic Alliances and the Backlash against Regulatory Reform Epilogue Notes Bibliography Index
by "Nielsen BookData"